跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
OXALIPLATIN ADVAGEN CONCENTRATE FOR SOLUTION FOR INFUSION 100MG/20ML - PPB Drug Approval Details
Approvals
/
PPB
/
OXALIPLATIN ADVAGEN CONCENTRATE FOR SOLUTION FOR INFUSION 100MG/20ML
Approved
STANDARD
OXALIPLATIN ADVAGEN CONCENTRATE FOR SOLUTION FOR INFUSION 100MG/20ML
ADVAGEN (H.K.) LIMITED
🇰🇪 Pharmacy and Poisons Board
Approval Date
Jun 21, 2024
Approval ID
e8a9db07534167c9
Company
ADVAGEN (H.K.) LIMITED
Type
Standard
Approval Details
Approval Id
e8a9db07534167c9
Product Name
OXALIPLATIN ADVAGEN CONCENTRATE FOR SOLUTION FOR INFUSION 100MG/20ML
Drug Hk Name
OXALIPLATIN ADVAGEN CONCENTRATE FOR SOLUTION FOR INFUSION 100MG/20ML
Registration Code
HK-67993
Company Name
ADVAGEN (H.K.) LIMITED
Company Detail Path
/organization/advagen-h-k-limited
Registration Category
Part 1, Schedule 1 & Schedule 3 Poison
Sale Requirement
Prescription only Medicines
Registration Date
2023-10-17
Company Address
RM 7B, ONE CAPITAL PLACE, 18 LUARD ROAD, WAN CHAI, HONG KONG
Active Ingredients
Approved
Quick Info
Agency
PPB
Country
🇰🇪
Approval Date
Jun 21, 2024
Approval ID
e8a9db07534167c9
Type
Standard
Back to PPB Approvals